Officer exercised or converted 10K JNJ derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 11, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 12, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000200406-26-000127
Added to OQROOct 2, 2026, 3:52 AM UTC Data qualityVerified: identifiers matched exactly Reporting personKathryn E Wengel Officer titleEVP, Chief TO and Risk Officer SecurityEmployee Stock Options (Right to Buy) TableDerivative (Table II) Transaction dateJun 11, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Around the same time
Congress tradeSits on House Ways and Means, Health5 different filers disclosed JNJ within 90 days. Disclosed 27 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.
124K → 114K shares held−8% of their stake
Johnson & Johnson's Chief TO and Risk Officer sold $2.41M of Johnson & Johnson shares. Nobody planned it ahead of time.
